Events Partner Content SMi's 9th Annual Orphan Drugs & Rare Diseases Conference Orphan Drugs & Rare Diseases
Partner Content Partner Content Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare ... Registration Opens for Orphan Drugs
Views & Analysis Patient access at risk: should stakeholders take an orchestr... Now is the time to work more harmoniously together to improve patient access to innovative treatments.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
